A61K 40/4524
Mycobacterium
Official title: {Mycobacterium, e.g. Mycobacterium tuberculosis}
A61K40/4524 (Mycobacterium) appears on 21 US grants and 40 published applications in this corpus.
Search patents in A61K- Granted patents
- 21
- Published applications
- 40
- Assignees
- 33
- Inventors
- 80
- Latest grant
- 13 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 2 |
| 2003 | 0 | 2 |
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 1 | 1 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 1 | 2 |
| 2010 | 0 | 0 |
| 2011 | 1 | 0 |
| 2012 | 0 | 3 |
| 2013 | 1 | 1 |
| 2014 | 1 | 1 |
| 2015 | 2 | 2 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 2 |
| 2019 | 0 | 2 |
| 2020 | 0 | 4 |
| 2021 | 3 | 6 |
| 2022 | 2 | 2 |
| 2023 | 3 | 3 |
| 2024 | 1 | 0 |
| 2025 | 1 | 3 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- BCG car constructs and methods of their manufacture and use13 Jan 2026US 12,522,651 B2Versiti Blood Research Institute Foundation, Inc.
- Systems for producing cellular immunotherapeutics and methods of use thereof17 Jun 2025US 12,331,279 B2Northeastern University
- Mycobacterial antigen compositions and methods of use17 Dec 2024US 12,168,046 B2Children's National Medical Center
- Vaccines comprising Mycobacterium leprae polypeptides for the prevention, treatment, and diagnosis of leprosy31 Oct 2023US 11,801,290 B2Access To Advanced Health Institute
- Systems for producing cellular immunotherapeutics and methods of use thereof26 Sep 2023US 11,767,500 B2Northeastern University
- Systems For Producing Cellular Immunotherapeutics And Methods Of Use Thereof30 Oct 2025US 2025/0333684 A1Northeastern University
- Phosphatidylserine targeting molecule combined with memory t cell antigen for therapeutic, diagnostic and adjuvant use18 Sep 2025US 2025/0289907 A1Rutgers, The State University of New Jersey
- Compositions comprising recombinant strains of mycobacterium, uses thereof and methods for the prevention and/or treatment of cancer8 May 2025US 2025/0144196 A1Instituto Butantan
- Systems For Producing Cellular Immunotherapeutics And Methods Of Use Thereof7 Dec 2023US 2023/0392106 A1Northeastern University
- Vaccines Comprising Mycobacterium Leprae Polypeptides for the Prevention, Treatment, and Diagnosis of Leprosy30 Nov 2023US 2023/0381292 A1Access To Advanced Health Institute
Most cited
By later US patents
- Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof5US 7,063,960 B2The Rockefeller University · 2006
- Modified epitopes for boosting CD4+ T-cell responses3US 10,899,795 B2Katholieke Universiteit Leuven · 2021
- Protein belonging to the TNF superfamily involved in signal transduction and methods of use thereof3US 7,622,442 B2The Rockefeller University · 2009
- Systems for producing cellular immunotherapeutics and methods of use thereof1US 11,371,008 B2Northeastern University · 2022
- Systems for producing cellular immunotherapeutics and methods of use thereof1US 11,767,500 B2Northeastern University · 2023